» Articles » PMID: 34284793

Hsa_circ_0000520 Overexpression Increases CDK2 Expression Via MiR-1296 to Facilitate Cervical Cancer Cell Proliferation

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2021 Jul 21
PMID 34284793
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Circular RNA (circRNA) has been demonstrated to participate in cervical cancer development. In this study, we analyzed the role of hsa_circ_0000520 in cervical cancer.

Methods: Fifty-two pairs of cervical cancer and adjacent normal tissue samples were collected, and five human cervical cancer cell lines were obtained followed by the detection of hsa_circ_0000520 expression. Nuclear-cytoplasmic isolation and fluorescence in situ hybridization were performed to analyze the subcellular localization of hsa_circ_0000520 while linear RNA was digested by RNase R. Gain- or loss-of function experiments on hsa_circ_0000520 were performed, followed by detection of cell proliferation and cell cycle by EdU, Cell Counting Kit-8, colony formation assay, and flow cytometry respectively.

Results: Hsa_circ_0000520 and cyclin-dependent kinase 2 (CDK2) were highly expressed in cervical cancer tissues. Binding sites between microRNA-1296 (miR-1296) and hsa_circ_0000520 or CDK2 were verified. Antibody to Argonaute 2 (Ago2) could precipitate hsa_circ_0000520, indicating that hsa_circ_0000520 could competitively bind to miR-1296 via Ago2. Silencing hsa_circ_0000520 inhibited cervical cancer cell proliferation and promoted the inhibitory effects of miR-1296 on CDK2, thereby blocking cell cycle progression and promoting apoptosis.

Conclusion: These results support the premise that targeting hsa_circ_0000520 can be a potential approach to combat cervical cancer.

Citing Articles

Circular RNA NINL accelerates the malignant progression of cervical cancer.

Cao C, Zhang H, Zhang T, Nie C Discov Oncol. 2024; 15(1):766.

PMID: 39692846 PMC: 11655911. DOI: 10.1007/s12672-024-01588-8.


Agrimonolide Inhibits the Malignant Progression of Non-small Cell Lung Cancer and Induces Ferroptosis through the mTOR Signaling Pathway.

Zhang X, Cai W, Yan Y Anticancer Agents Med Chem. 2024; 24(18):1371-1381.

PMID: 39129291 DOI: 10.2174/0118715206305421240715042502.


Circular RNAs in Cell Cycle Regulation of Cancers.

Thamjamrassri P, Ariyachet C Int J Mol Sci. 2024; 25(11).

PMID: 38892280 PMC: 11173060. DOI: 10.3390/ijms25116094.


Hsa_circ_0000078 Regulates miR-205-5p/EREG Pathway to Inhibit Cervical Cancer Progression.

Liu C, Li Y Mol Biotechnol. 2023; 65(9):1453-1464.

PMID: 36645579 DOI: 10.1007/s12033-023-00658-6.


A review on the role of cyclin dependent kinases in cancers.

Ghafouri-Fard S, Khoshbakht T, Hussen B, Dong P, Gassler N, Taheri M Cancer Cell Int. 2022; 22(1):325.

PMID: 36266723 PMC: 9583502. DOI: 10.1186/s12935-022-02747-z.


References
1.
Yu D, Li Y, Ming Z, Wang H, Dong Z, Qiu L . Comprehensive circular RNA expression profile in radiation-treated HeLa cells and analysis of radioresistance-related circRNAs. PeerJ. 2018; 6:e5011. PMC: 6005163. DOI: 10.7717/peerj.5011. View

2.
Majid S, Dar A, Saini S, Chen Y, Shahryari V, Liu J . Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res. 2010; 70(7):2809-18. DOI: 10.1158/0008-5472.CAN-09-4176. View

3.
Kristensen L, Hansen T, Veno M, Kjems J . Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2017; 37(5):555-565. PMC: 5799710. DOI: 10.1038/onc.2017.361. View

4.
Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong F . Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol Cancer. 2018; 17(1):79. PMC: 5889847. DOI: 10.1186/s12943-018-0827-8. View

5.
Qian W, Huang T, Feng W . Circular RNA HIPK3 Promotes EMT of Cervical Cancer Through Sponging miR-338-3p to Up-Regulate HIF-1α. Cancer Manag Res. 2020; 12:177-187. PMC: 6957911. DOI: 10.2147/CMAR.S232235. View